- Home
- QDEL vs XOMAO Comparison
QDEL vs XOMAO Comparison
Compare QDEL & XOMAO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QDEL
- XOMAO
- Stock Information
- Founded
- QDEL 1979
- XOMAO N/A
- Country
- QDEL United States
- XOMAO United States
- Employees
- QDEL N/A
- XOMAO 13
- Industry
- QDEL Medical Specialities
- XOMAO Biotechnology: Pharmaceutical Preparations
- Sector
- QDEL Health Care
- XOMAO Health Care
- Exchange
- QDEL Nasdaq
- XOMAO Nasdaq
- Market Cap
- QDEL N/A
- XOMAO N/A
- IPO Year
- QDEL N/A
- XOMAO N/A
- Fundamental
- Price
- QDEL $43.02
- XOMAO $25.30
- Analyst Decision
- QDEL Buy
- XOMAO
- Analyst Count
- QDEL 8
- XOMAO 0
- Target Price
- QDEL $53.43
- XOMAO N/A
- AVG Volume (30 Days)
- QDEL 897.8K
- XOMAO N/A
- Earning Date
- QDEL 02-12-2025
- XOMAO N/A
- Dividend Yield
- QDEL N/A
- XOMAO N/A
- EPS Growth
- QDEL N/A
- XOMAO N/A
- EPS
- QDEL N/A
- XOMAO N/A
- Revenue
- QDEL $2,817,700,000.00
- XOMAO N/A
- Revenue This Year
- QDEL N/A
- XOMAO N/A
- Revenue Next Year
- QDEL N/A
- XOMAO N/A
- P/E Ratio
- QDEL N/A
- XOMAO N/A
- Revenue Growth
- QDEL N/A
- XOMAO N/A
- 52 Week Low
- QDEL $29.74
- XOMAO N/A
- 52 Week High
- QDEL $69.83
- XOMAO N/A
- Technical
- Relative Strength Index (RSI)
- QDEL 45.19
- XOMAO 50.03
- Support Level
- QDEL $42.00
- XOMAO $25.32
- Resistance Level
- QDEL $46.24
- XOMAO $25.40
- Average True Range (ATR)
- QDEL 1.81
- XOMAO 0.08
- MACD
- QDEL -0.26
- XOMAO 0.02
- Stochastic Oscillator
- QDEL 46.18
- XOMAO 85.71
About XOMAO AGNC Investment Corp.
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. When XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes.